APA (7th ed.) Citation

Schott, A., Simon, T., Müller, S., Rausch, A., Busch, B., Glaß, M., . . . Bley, N. (2025). The IGF2BP1 oncogene is a druggable m6A-dependent enhancer of YAP1-driven gene expression in ovarian cancer. NAR: cancer, 7(1), . https://doi.org/10.1093/narcan/zcaf006

Chicago Style (17th ed.) Citation

Schott, Annekatrin, et al. "The IGF2BP1 Oncogene Is a Druggable M6A-dependent Enhancer of YAP1-driven Gene Expression in Ovarian Cancer." NAR: Cancer 7, no. 1 (2025). https://doi.org/10.1093/narcan/zcaf006.

MLA (9th ed.) Citation

Schott, Annekatrin, et al. "The IGF2BP1 Oncogene Is a Druggable M6A-dependent Enhancer of YAP1-driven Gene Expression in Ovarian Cancer." NAR: Cancer, vol. 7, no. 1, 2025, https://doi.org/10.1093/narcan/zcaf006.